Transaction #16767 · Form 4 · 0001336504-25-000007
Guardant Health, Inc. · Exercise / conversion · Common Stock
Guardant Health, Inc. · Transacted December 5, 2025 · Filed December 8, 2025
What does this filing report?
An SEC Form 4 filing for Guardant Health, Inc. records an exercise / conversion involving Common Stock on December 5, 2025. The reported quantity was 8,803. The filing date is December 8, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Guardant Health, Inc.
- Company CIK
- 0001576280
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 8,803
- Reported price
- 38.005
- Reference value
- 334,558.015
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 27,759
- Ownership description
- By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account
- SEC acceptance time
- Dec 8, 2025, 9:36 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- CLARK IAN T ↗
Director
CIK 0001336504
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.88 to $106.87. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2
- Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.88 to $107.87. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3
- Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.885 to $108.480. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4
- The Stock Options vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier.
- F5
- The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.
- F6
- The stock option vests in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.